About us

Short history and boardmembers

In 2011, a group of entrepreneurs invested in a philanthropic effort to treat cancer via this discovery. Together with the inventor of the original ISCOM technology, the group created a business structure, bringing in additional expertise and founded several companies focused to exploiting the patent portfolio in cancer therapy.


Thomas Zetterberg Chairman thomas.zetterberg@canqura.com
Johan Monie Managing Director, Board Member johan.monie@canqura.com
Lars Monie Board Member monie@skrallinge.com